Inventor · disambiguated record
Ming-Chu Hsu
Also filed as: HSU MING-CHU
15 granted patents·5 pending applications·223 citations·filing 1989–2019
93Inventor score
Files withTAIGEN BIOTECHNOLOGY CO LTD6HOFFMANN LA ROCHE5NAT HEALTH RESEARCH INSTITUTES4HSU MING-CHU2TTY BIOPHARM CO LTD1
Top patents by PatentIndex Score
20 records- 0190US10004719B1Solid dispersion formulationTAIGEN BIOTECHNOLOGY CO LTD·Filed 2017·Granted Jun 26, 2018·12 cites·29 claims
- 0282US6706739B2Imidazolidinone compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2002·Granted Mar 16, 2004·15 cites·38 claims
- 0382US5070010AMethod for determining anti-viral transactivating activityHOFFMANN LA ROCHE·Filed 1989·Granted Dec 3, 1991·76 cites·15 claims
- 0481US6903104B2Indol-3-YL-2-oxoacetamide compounds and methods of use thereofNAT HEALTH RESEARCH INSTITUTES·Filed 2002·Granted Jun 7, 2005·15 cites·15 claims
- 0579US7396838B2Use of 1H-indol-3-yl-2-oxoacetamide compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2005·Granted Jul 8, 2008·2 cites·8 claims
- 0678US7462594B2Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteasesTAIGEN BIOTECHNOLOGY CO LTD·Filed 2005·Granted Dec 9, 2008·2 cites·2 claims
- 0778US5041438AMethod for treating retroviral infections with benzodiazepine compoundsHOFFMANN LA ROCHE·Filed 1989·Granted Aug 20, 1991·57 cites·6 claims
- 0873US10596171B2Cap-dependent endonuclease inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2019·Granted Mar 24, 2020·2 cites·18 claims
- 0969US9375406B2Substituted pyrimidines for mobilizing cells expressing a type 4 CXC chemokine receptorTAIGEN BIOTECHNOLOGY CO LTD·Filed 2014·Granted Jun 28, 2016·1 cites·10 claims
- 1069US8211909B2Treatment of antibiotic-resistant bacteria infectionHSU MING-CHU·Filed 2008·Granted Jul 3, 2012·2 cites·12 claims
- 1165US7662834B2Methods of 1H-indol-3-yl-2-oxoacetamide compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2008·Granted Feb 16, 2010·0 cites·14 claims
- 1262US5141735ASubstituted amino-benzodiazepines having anitviral activityHOFFMANN LA ROCHE·Filed 1990·Granted Aug 25, 1992·19 cites·13 claims
- 1353US2005003405A1Treatment and diagnostics of cancerFiled 2004·Application pending·0 cites
- 1449US10377714B2Trans-isomeric heterocyclic compounds and preparation thereofTAIGEN BIOTECHNOLOGY CO LTD·Filed 2017·Granted Aug 13, 2019·0 cites·28 claims
- 1546US2010041697A1Pneumonia treatmentTAIGEN BIOTECHNOLOGY CO LTD·Filed 2009·Application pending·0 cites
- 1644US5036101AMethod for treating retroviral infections with aryl-(2-pyrryl) ketone compoundHOFFMANN LA ROCHE·Filed 1989·Granted Jul 30, 1991·10 cites·6 claims
- 1743US5164376AMethod for treating retroviral infections with aryl-(2-pyrryl) keytone compoundHOFFMANN LA ROCHE·Filed 1990·Granted Nov 17, 1992·10 cites·6 claims
- 1843US2012157492A1Antibiotic drugHSU MING-CHU·Filed 2009·Application pending·0 cites
- 1940US2020330508A1Compositions for prevention or suppression of cancer or cancer relapseWANG FU NAN·Filed 2019·Application pending·0 cites
- 2035US2001018445A1Pharmaceutical composition for the treatment of hepatocellular carcinomaTTY BIOPHARM CO LTD·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ming-Chu Hsu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →